FTSE MIB
34.648,49 +309,17 (+0,90%) Dow Jones
39.485,00 +97,24 (+0,25%) Nasdaq
16.329,80 -16,46 (-0,10%) Nikkei 225
38.229,11 +155,13 (+0,41%) Petrolio
79,40 +0,14 (+0,18%) Bitcoin EUR
57.002,64 -44,04 (-0,08%)
Windtree Therapeutics, Inc. (WINT)
| Chiusura precedente | 4,3400 |
| Aperto | 4,4900 |
| Denaro | 3,1300 x 200 |
| Lettera | 5,4400 x 200 |
| Min-Max giorno | 4,3001 - 4,4100 |
| Intervallo di 52 settimane | 4,1800 - 35,1000 |
| Volume | |
| Media Volume | 22.887 |
| Capitalizzazione | 2,194M |
| Beta (5 anni mensile) | 0,61 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -94,3200 |
| Prossima data utili | 13 mag 2024 - 17 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 3,00 |
GlobeNewswireWindtree to Present at the ThinkEquity Conference on October 19th in New York City
WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will be presenting at the upcoming ThinkEquity Conference on Thursday, October 19, 2023 at 4:30pm ET. Windtree management will also be hosting 1x1 meetings with investors at the event. The presentati
- GlobeNewswire
Windtree to Participate in the Lytham Partners Fall 2023 Investor Conference on October 17th
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will be participating in a panel discussion titled, “Cardiac Kids: Late-Stage Advancement for Cardiovascular Disorders,” at the Lytham Partners Fall 2023 Investor Conference on Tuesday, October 17, 2
- GlobeNewswire
Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th
WARRINGTON, Pa., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser, President and Chief Executive Officer, will be presenting at the upcoming Dawson James Small Cap Growth Conference on October 12, 2023 in Jupiter, FL. The presentation will provide clinical development and business updates including Windt
